Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

ClinicalTrials.gov ID: NCT00516958

Public ClinicalTrials.gov record NCT00516958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Three Arm, Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care vs. Oral Levofloxacin vs. Combined Therapy for Mild Diabetic Foot Infections

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare the rates of clinical success of Topical Dermacyn™ vs. Oral Levofloxacin vs. Combined therapy, in subjects with mild diabetic foot infections in non-ischemic ulcers.

Study identification

NCT ID
NCT00516958
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
65 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2007 (Type not available)
Primary completion
Dec 2007 (Actual)
Completion
Dec 2007 (Actual)
Last update posted
Jan 14, 2008

2007

United States locations

U.S. sites
16
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
Not listed Tucson Arizona 85710 —
Not listed La Jolla California 92037 —
Not listed Los Angeles California 90063-2326 —
Not listed San Diego California 92103-8896 —
Not listed Santa Rosa California 34669 —
Not listed Denver Colorado 80220 —
Not listed New Haven Connecticut 06515 —
Not listed Boca Raton Florida 33486 —
Not listed Spring Hill Florida 34609 —
Not listed Evansville Indiana 47714 —
Not listed Louisville Kentucky 40222 —
Not listed Boston Massachusetts 02215 —
Not listed Harrisburgh Pennsylvania 17112 —
Not listed Hazleton Pennsylvania 18201 —
Not listed Pittsburgh Pennsylvania 15224 —
Not listed Salt Lake City Utah 54102 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00516958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 14, 2008 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00516958 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →